Epoxyeicosanoids promote organ and tissue regeneration
- 29 July 2013
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 110 (33), 13528-13533
- https://doi.org/10.1073/pnas.1311565110
Abstract
Epoxyeicosatrienoic acids (EETs), lipid mediators produced by cytochrome P450 epoxygenases, regulate inflammation, angiogenesis, and vascular tone. Despite pleiotropic effects on cells, the role of these epoxyeicosanoids in normal organ and tissue regeneration remains unknown. EETs are produced predominantly in the endothelium. Normal organ and tissue regeneration require an active paracrine role of the microvascular endothelium, which in turn depends on angiogenic growth factors. Thus, we hypothesize that endothelial cells stimulate organ and tissue regeneration via production of bioactive EETs. To determine whether endothelial-derived EETs affect physiologic tissue growth in vivo, we used genetic and pharmacological tools to manipulate endogenous EET levels. We show that endothelial-derived EETs play a critical role in accelerating tissue growth in vivo, including liver regeneration, kidney compensatory growth, lung compensatory growth, wound healing, corneal neovascularization, and retinal vascularization. Administration of synthetic EETs recapitulated these results, whereas lowering EET levels, either genetically or pharmacologically, delayed tissue regeneration, demonstrating that pharmacological modulation of EETs can affect normal organ and tissue growth. We also show that soluble epoxide hydrolase inhibitors, which elevate endogenous EET levels, promote liver and lung regeneration. Thus, our observations indicate a central role for EETs in organ and tissue regeneration and their contribution to tissue homeostasis.Keywords
This publication has 49 references indexed in Scilit:
- Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytesProstaglandins & Other Lipid Mediators, 2011
- Impact of Fibroblast Growth Factor-Binding Protein–1 Expression on Angiogenesis and Wound HealingThe American Journal of Pathology, 2011
- Endothelial-Derived Angiocrine Signals Induce and Sustain Regenerative Lung AlveolarizationCell, 2011
- Inductive angiocrine signals from sinusoidal endothelium are required for liver regenerationNature, 2010
- Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogsEuropean Journal of Pharmaceutical Sciences, 2010
- Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesNature Reviews Drug Discovery, 2009
- The Role of Vascular Endothelial Growth Factor in Wound HealingJournal of Surgical Research, 2009
- Genetic Interaction of PGE2 and Wnt Signaling Regulates Developmental Specification of Stem Cells and RegenerationCell, 2009
- PPARα agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibitionProceedings of the National Academy of Sciences of the United States of America, 2008
- Orally Bioavailable Potent Soluble Epoxide Hydrolase InhibitorsJournal of Medicinal Chemistry, 2007